Shimadzu Corporation · TSE:7701
Shimadzu — Investor Presentation (May 2022)
23 slides from Shimadzu's investor presentation, May 11, 2022
Slide 1: FY 2020-2022 Medium-Term Management Plan (Update)
FY 2020-2022 Medium-Term Management Plan (Update Due to the Upward Adjustment of Performance Targets) May 11, 2022 Yasunori Yamamoto President & CEO Shimadzu Corporation
Slide 2: Contents for Today
Contents for Today —Update Due to the Upward Adjustment of Performance Targets— I. Overview of the Current Medium-Term II. Strategic Measures in the Current Medium-Term Management Plan ･･･････ p. 4-p. 11 Management Plan ･･･････ p. 13-p. 22 • Changes in Business Environment Due to the • Strengthening
Slide 3: I. Overview of the Current Medium-Term Management Plan
I. Overview of the Current Medium-Term Management Plan I. Overview of the Current Medium-Term Management Plan ･･･････ p. 4-p. 11 • Basic Concept • Key Points of the Current Medium-Term Management Plan • Ongoing Measures for Infectious Diseases: Infectious Disease Countermeasure Projects • Four Growt
Slide 4: Basic Concept: Become a Company That Solves Challenges in Society
No Change I. Overview of the Current Medium-Term Management Plan—1/7 Basic Concept: Become a Company That Solves Challenges in Society in Collaboration with Partners All Around the World During the previous medium-term management plan, we started initiatives to “become a company that solves challe
Slide 5: Key Points of the Current Medium-Term Management Plan
I. Overview of the Current Medium-Term Management Plan—2/7 Key Points of the Current Medium-Term Management Plan Become a Company That Solves Challenges in Society in Collaboration with Slogan Partners All Around the World —Creating and Implementing Systems for Solving Challenges in Society— New: Ne
Slide 6: Infectious Disease Countermeasure Projects—Progress after Second Year
I. Overview of the Current Medium-Term Management Plan—3/7 Infectious Disease Countermeasure Projects—Progress after Second Year— We have implemented collaborations in and outside Japan for preventing infections, such as developing new testing methods and building testing data management systems.
Slide 7: Infectious Disease Countermeasure Projects—Transitioning to Ongoing Measures
Newly Added on May 11, 2022 I. Overview of the Current Medium-Term Management Plan—3/7 Infectious Disease Countermeasure Projects—Transitioning to Ongoing Measures— Strengthen reagent development and manufacturing. Start new measures for monitoring sewer water and facility effluent water. Stre
Slide 8: Four Growth Strategies
No Change I. Overview of the Current Medium-Term Management Plan—4/7 Four Growth Strategies Four Growth Strategies Key Measures Strengthen competitiveness and develop new applications/markets for key product lines, mainly liquid chromatographs (LC) and mass spectrometers (MS), and increase market
Slide 9: Investment in Capital Equipment and R&D
I. Overview of the Current Medium-Term Management Plan—5/7 Investment in Capital Equipment and R&D During FY 2020 and FY 2021, investment levels were impacted by the pandemic, but are now steadily recovering. During FY 2022, accelerate investments intended for achieving future growth. Capital eq
Slide 10: Performance Targets
I. Overview of the Current Medium-Term Management Plan—6/7 Performance Targets FY 2022 Corrected Performance Targets Net sales of 455.0 billion yen (25.0 billion yen higher than original), operating income of 68.0 billion yen (+11.0 billion yen), and operating margin of 14.9 % (+1.6 pt) (Original ta
Slide 11: Capitalization Policy
I. Overview of the Current Medium-Term Management Plan—7/7 Capitalization Policy Invest for future growth, mainly in R&D and capital equipment, provide value to stakeholders, and contribute to society. We will continue to maintain stable dividends based on a target 30 % total shareholder return.
Slide 12: II. Strategic Measures in the Current Medium-Term Management Plan
II. Strategic Measures in the Current Medium-Term Management Plan II. Strategic Measures in the Current Medium-Term Management Plan ･･･････ p. 13-p. 22 • Strengthening the Foundation for Growth: Reforming Business Portfolios • Sales Target by Business Segment • Strengthening Key Businesses for Analy
Slide 13: Strengthening the Foundation for Growth—Reforming Business Portfolios
No Change II. Strategic Measures in the Current Medium-Term Management Plan—1/10 Strengthening the Foundation for Growth—Reforming Business Portfolios— Improve the profitability of current businesses and reassess the future growth potential of each business and business category. Create new busi
Slide 14: Net Sales by Business Segment—Plan
II. Strategic Measures in the Current Medium-Term Management Plan—2/10 Net Sales by Business Segment—Plan— Analytical & Measuring Instruments: Given strong investment activity in pharmaceuticals and life sciences, expand LC and MS key models and recurring revenue businesses and strengthen carbon-n
Slide 15: Strengthening Key Businesses: Liquid Chromatographs (LC)
II. Strategic Measures in the Current Medium-Term Management Plan—3/10 Strengthening Key Businesses for Analytical & Measuring Instruments Segment (1) —Liquid Chromatographs (LC)— Policies: (1) Expand line of pretreatment/detector products, etc., (2) Strengthen core products, (3) Expand/improve dedi
Slide 16: Strengthening Key Businesses: Mass Spectrometers (MS)
II. Strategic Measures in the Current Medium-Term Management Plan—4/10 Strengthening Key Businesses for Analytical & Measuring Instruments Segment (2) —Mass Spectrometers (MS)— Policies: (1) Expand product lines, (2) Strengthen application systems, and (3) Strengthen databases Units: FY 2019 FY 2021
Slide 17: Strengthening Businesses outside Japan
II. Strategic Measures in the Current Medium-Term Management Plan—5/10 Strengthening Businesses outside Japan —Strengthening Innovation Centers and Manufacturing/Sales Functions— Innovation Centers: Create new value that can be offered by working together with customers to help improve understandi
Slide 18: Implementing DX Measures
II. Strategic Measures in the Current Medium-Term Management Plan—6/10 Implementing DX Measures Globally expand/improve offering of optimized products, information, and services (business DX) and continue performing business processes more intelligently to support such offerings (business process
Slide 19: Strengthening Businesses with Recurring Revenues
No Change II. Strategic Measures in the Current Medium-Term Management Plan—7/10 Strengthening Businesses with Recurring Revenues —Deploying New Businesses with Recurring Revenues Using AI/IoT Technologies— Use AI, IoT, or other technologies to launch new forms of business that generate subscripti
Slide 20: Expanding Business in Four Growth Fields—Promoting Solutions in Society
II. Strategic Measures in the Current Medium-Term Management Plan—8/10 Expanding Business in Four Growth Fields—Promoting Solutions in Society— Specify specific areas to target for creating new businesses, such as dementia examinations/interventions or infectious disease testing, develop products
Slide 21: Measures for Achieving Carbon Neutrality
Newly Added on May 11, 2022 II. Strategic Measures in the Current Medium-Term Management Plan—9/10 Measures for Achieving Carbon Neutrality Measures in Existing Businesses Future Measures “Forming Global Partnerships” and “International Standardization” “CO2 Capture and Storage” and “CO2 Reuse (Biop
Slide 22: Implementing Sustainability Management
Changed May 11, 2022 II. Strategic Measures in the Current Medium-Term Management Plan—10/10 Implementing Sustainability Management Created the Shimadzu Group Sustainability Charter, and the Sustainability Management Implementation Policy with an emphasis on contribution through business activitie
Slide 23: Cautionary note on forecasts
Actual results may differ from forecasts about future performance indicated in this document, due to disasters, or fluctuations in economic conditions, exchange rates, technologies, or a variety of other external factors.